Current data support the notion that high B4GALNT2 is causally related to a better prognosis because it can reduce stemness and capability to grow in poorly adherent conditions, and it increases the propensity to apoptosis and stimulates anti-cancer immunity. The gene discussed is B4GALNT2; the disease is cancer.